The first stop for professional medicines advice

Disposing of both Comirnaty Concentrate Vaccines at PCN Designated Sites

Tracy Rogers, Director, Medicines Use & Safety, Medicines Use and Safety TeamPublished Last updated See all updates
Topics: AdultsDisposalPaediatrics · Pfizer-BioNTech: HandlingPrimary Care and PCNsStandard Operating Procedures ·

SOP for safe disposal of Comirnaty concentrate for Children 5-11 years and Comirnaty concentrate for adults and adolescents at PCN sites

Information

A standard operating procedure is attached to this page.

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in Community Pharmacy settings.

You should also familiarise yourself with our background guide before using this SOP.

Background guide

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

COVID-19 Vaccination
We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
Ask for help
If you're a healthcare professional who needs further advice, get in touch with us. We answer questions about Medicines Optimisation issues, including those about the COVID-19 vaccination programme. Help us to help you: tell us where on our site you were.

Change history

  1. Changed throughout to include Children 5-11 years product. Removal of reference to Regulation 174 product.
  1. The current content is still accurate.
  1. PVH5 - Amendment of content and scope to include requirements for use of Regulation 174 and licensed Comirnaty products. Removal of waste code table.
  1. Addition of wording to webpage referring to use within Community Pharmacy settings.
  1. Amendment to details for carton destruction
  1. Published